Pharmacological Management of Cardiovascular Health Quiz

Diuretics are commonly used as first-line therapy for hypertension to reduce blood volume and lower blood pressure.

Isosorbide mononitrate is commonly used as a vasodilator in the treatment of angina pectoris, dilating coronary arteries to improve blood flow.

Streptokinase is commonly used for the management of acute myocardial infarction by dissolving blood clots in coronary arteries.

Carvedilol is commonly used as a first-line treatment for heart failure with reduced ejection fraction, exerting beta-blocking and alpha-blocking effects.

Isosorbide mononitrate is commonly used as a first-line treatment for stable angina, providing relief by dilating coronary arteries and improving blood flow.

Statins manage cardiovascular health by lowering LDL cholesterol levels, reducing the risk of atherosclerosis and cardiovascular events.

Aspirin irreversibly inhibits platelet aggregation, preventing blood clot formation and reducing the risk of cardiovascular events.

Metoprolol is commonly used for rate control in atrial fibrillation by slowing heart rate and maintaining a steady rhythm.

ACE inhibitors inhibit angiotensin II production, leading to vasodilation, reduced blood volume, and improved cardiac function.

Dabigatran is a direct thrombin inhibitor used for stroke prevention in atrial fibrillation by preventing blood clot formation.

Heparins are primarily used for the prevention of venous thromboembolism by inhibiting blood clot formation.

Beta-blockers are typically used as a first-line treatment for stable angina by reducing heart rate, blood pressure, and myocardial oxygen demand.

Nitroglycerin is used for the prevention of angina attacks but is contraindicated in patients with hypotension due to its vasodilatory effects.

Sacubitril/valsartan is commonly used to improve symptoms and decrease hospitalizations in patients with heart failure with preserved ejection fraction by inhibiting the renin-angiotensin-aldosterone system and promoting vasodilation.

Cilostazol is commonly used to reduce the risk of cardiovascular events in patients with peripheral artery disease (PAD) by improving blood flow and inhibiting platelet aggregation.